Skip to Main Content

Paper Details

Association of CYP2C9*2 with bosentan-induced liver injury.
Clin Pharmacol Ther
39
2013
ABCB11, ABCC2, ALT, AST, Bosentan, CYP2C9, CYP2C9*1, CYP2C9*2, CYP2C9*3, DILI, PAH, SLCO1B1, SLCO1B3, Tracleer, alanine, alanine aminotransferase, aspartate, aspartate aminotransferase, bosentan, drug, endothelin receptor, liver injury, patients, pulmonary arterial hypertension

Datasets

Release 1.2